LCE2D Inhibitors
LCE2D Inhibitors are chemical compounds that interfere with various signaling pathways and biological processes to diminish the functional activity of LCE2D, a protein involved in the epidermal differentiation complex. Cyclosporin A, for instance, inhibits T-cell activation by preventing the transcription of IL-2 and its receptor through calcineurin inhibition, thereby reducing the signaling cascade that leads to LCE2D expression. Hydrocortisone and Indomethacin, both anti-inflammatory agents, decrease the production of inflammatory mediators, curbing pathways that could upregulate LCE2D during stress responses in the skin. 13-cis-Retinoic acid, a retinoic acid derivative, downregulates LCE2D by promoting keratinocyte differentiation, while Imiquimod diverts immune-related pathways away from inducing LCE2D expression. FK-506, through calcineurin inhibition, reduces cytokine production, thus indirectly affecting pathways that upregulate LCE2D during immune responses. Methotrexate's inhibition of cell proliferation in the epidermis indirectly reduces LCE2D expression, as it is part of the epidermal differentiation process.
Further influencing the expression of LCE2D, Bexarotene, acting as a retinoid X receptor agonist, modulates genes related to skin proliferation and differentiation, which can lead to decreased LCE2D expression. Similarly, Apigenin, Curcumin, and Glycyrrhizic acid all exhibit anti-inflammatory properties that suppress inflammatory signaling and immune responses, indirectly leading to reduced LCE2D expression. Apigenin inhibits keratinocyte proliferation, Curcumin modulates the NF-κB pathway, and Glycyrrhizic acid affects the immune response through various targets including 11β-hydroxysteroid dehydrogenase. Collectively, these inhibitors utilize their distinct mechanisms to reduce the functional activity of LCE2D without affecting the protein's transcription or translation, focusing instead on the specific pathways and processes that are directly involved in its regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A binds to the cytosolic protein cyclophilin of T-lymphocytes, inhibiting calcineurin. This leads to diminished transcription of IL-2 and its receptor, which are crucial for T-cell activation. As LCE2D is involved in the epidermal differentiation complex and its expression can be induced by immune signals, inhibiting T-cell activation diminishes the signaling cascade that leads to LCE2D expression. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone is a corticosteroid that can inhibit phospholipase A2, leading to reduced production of inflammatory mediators like prostaglandins and leukotrienes. This anti-inflammatory action can reduce the activation of pathways that may increase LCE2D expression in stress-induced epidermal responses. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid, a retinoic acid derivative, normalizes keratinocyte differentiation and decreases sebum production. It indirectly diminishes LCE2D expression by promoting the differentiation of keratinocytes and potentially downregulating proteins involved in the epidermal differentiation complex. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod acts as an immune response modifier by binding to toll-like receptor 7, leading to increased production of pro-inflammatory cytokines. As LCE2D expression is associated with skin barrier formation and defense mechanisms, imiquimod’s action can shift the immune-related pathways away from those that induce LCE2D expression. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK-506 binds to FKBP12, forming a complex that inhibits calcineurin, thus reducing the activity of NFAT (nuclear factor of activated T-cells), which is involved in the transcription of various cytokines. As LCE2D is implicated in the epidermal defense response, the diminished cytokine production indirectly decreases the pathways that could upregulate LCE2D expression during an immune response. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a dihydrofolate reductase inhibitor, leading to decreased DNA synthesis. It acts to reduce the proliferation of rapidly dividing cells, including those in the epidermis where LCE2D is expressed. By inhibiting cell proliferation, methotrexate indirectly reduces the expression of LCE2D as part of the epidermal differentiation process. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene is a retinoid X receptor agonist that modulates the transcription of genes involved in skin proliferation and differentiation. This agonistic action can lead to altered expression of proteins in the epidermal differentiation complex, indirectly leading to diminished LCE2D expression. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin is a flavonoid that has been shown to inhibit keratinocyte proliferation and has anti-inflammatory properties. By reducing cellular proliferation and inflammation in the epidermis, apigenin indirectly diminishes the expression of LCE2D. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin exhibits anti-inflammatory and antioxidant properties. It can modulate the NF-κB pathway, leading to reduced expression of inflammatory cytokines. As inflammation can induce LCE2D expression, curcumin’s action indirectly reduces LCE2D expression by tempering the inflammatory response in the epidermis. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
Glycyrrhizic acid has anti-inflammatory and immunomodulatory effects by inhibiting 11β-hydroxysteroid dehydrogenase and high-mobility group box 1. This inhibition leads to decreased inflammation and an altered immune response that may indirectly diminish the upregulation of LCE2D in inflammatory skin conditions. | ||||||